We reported a negative effect of serum uric acid (SUA) level on the development of coronary collateral vessel (CCV) in patients with acute coronary syndrome (ACS). 1 We read with interest the letter to the editor by Hsu et al 2 about an association between SUA and CCV.
Hsu et al 2 reviewed their coronary angiographic data to look for similar result in a Chinese population. They reported that SUA level did not have a significant association with the presence and development of CCV.
Differing from the study by Hsu et al, 2 we excluded patients with a history of diabetes mellitus, hypertension, renal disease, past coronary intervention or coronary artery bypass grafting, inflammatory rheumatic disease, and chronic obstructive pulmonary disease. All these parameters may affect the development of collaterals and/or levels of SUA. [3] [4] [5] Hsu et al 2 did not report exclusion criteria clearly in their study, and they included diabetic and hypertensive patients. Although the number of diabetic and hypertensive patients was similar in both groups, it is very difficult to predict the exact effects of hypertension and diabetes on the development of collaterals. Because abnormal values of liver function tests and triglycerides can affect SUA levels and vascular risk, we excluded patients with abnormal liver function tests and triglycerides. 3, 6 Endothelial dysfunction and decreased nitric oxide (NO) production were suggested as an underlying mechanism for the absence of CCVs, 7 and SUA contributes directly to the endothelial dysfunction by inducing antiproliferative effects and impairing NO production. 8 The SUA is associated with high oxidative stress, formation of free radicals, and facilitates lipid peroxidation, which are important factors in both angiogenesis and atherogenesis. 9, 10 Because of the negative effects of SUA on angiogenesis and atherogenesis, we hypothesized that in nondiabetic, nonhypertensive patients with ACS, high levels of SUA affect the CCV development negatively in our study. Hyperuricemia may also cause microvascular damage in the renal vascular bed and exacerbate vascular disease. 11 Similarly, as our results showed, high SUA levels may cause damage in microvascular coronary vessels and may result in poorly developed CCV or absence of collaterals.
We know that myocardial ischemia is one of the important determinants of coronary collateral development. 12 Hsu et al 2 reported that the patients with poor CCV had fewer diseased vessels. In our study, there was no association between the burden of coronary artery disease and the development of collaterals. The results might have been different (at least in multivariate analysis) if we had evaluated the effect of burden of coronary artery disease.
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